ASX - Delayed Quote AUD

Universal Biosensors, Inc. (UBI.AX)

0.0480
-0.0020
(-4.00%)
At close: 4:10:20 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
6,282.7380
6,282.7380
6,632.8380
4,524.9620
5,777.7510
Cost of Revenue
2,280.5050
2,280.5050
2,347.9010
2,385.9310
3,672.0570
Gross Profit
4,002.2330
4,002.2330
4,284.9370
2,139.0310
2,105.6940
Operating Expense
18,766.0770
18,766.0770
17,449.3280
21,217.4690
13,093.2340
Operating Income
-14,763.8440
-14,763.8440
-13,164.3910
-19,078.4380
-10,987.5400
Net Non Operating Interest Income Expense
343.9600
343.9600
556.9900
164.0760
-71.9630
Other Income Expense
180.1410
180.1410
5,865.8370
-10,991.0270
552.5680
Pretax Income
-14,239.7430
-14,239.7430
-6,741.5640
-29,905.3890
-10,506.9350
Tax Provision
0
0
0
-3,050.8370
0
Net Income Common Stockholders
-14,239.7430
-14,239.7430
-6,741.5640
-26,854.5520
-10,506.9350
Diluted NI Available to Com Stockholders
-14,239.7430
-14,239.7430
-6,741.5640
-26,854.5520
-10,506.9350
Basic EPS
-0.05
--
-0.03
-0.14
-0.06
Diluted EPS
-0.05
--
-0.03
-0.14
-0.06
Basic Average Shares
270,384.4700
--
212,369.4350
198,724.9100
177,714.2010
Diluted Average Shares
270,384.4700
--
212,369.4350
198,724.9100
177,714.2010
Total Operating Income as Reported
-16,968.4640
-16,968.4640
-16,680.3210
-34,893.6770
-15,038.0840
Total Expenses
21,046.5820
21,046.5820
19,797.2290
23,603.4000
16,765.2910
Net Income from Continuing & Discontinued Operation
-14,239.7430
-14,239.7430
-6,741.5640
-26,854.5520
-10,506.9350
Normalized Income
-14,230.2040
-14,230.2040
-6,711.3870
-16,859.7240
-10,784.0540
Interest Income
446.7790
446.7790
734.3750
381.5970
49.9470
Interest Expense
20.5420
20.5420
20.3860
18.1510
0
Net Interest Income
343.9600
343.9600
556.9900
164.0760
-71.9630
EBIT
-14,219.2010
-14,219.2010
-6,721.1780
-29,887.2380
-10,506.9350
EBITDA
-13,415.9320
-13,415.9320
-5,751.5070
-27,101.6030
-7,940.2160
Reconciled Cost of Revenue
2,280.5050
2,280.5050
2,334.5050
2,249.9670
3,282.0890
Reconciled Depreciation
803.2690
803.2690
969.6710
2,785.6350
2,566.7190
Net Income from Continuing Operation Net Minority Interest
-14,239.7430
-14,239.7430
-6,741.5640
-26,854.5520
-10,506.9350
Total Unusual Items Excluding Goodwill
-9.5390
-9.5390
-30.1770
-11,130.3000
277.1190
Total Unusual Items
-9.5390
-9.5390
-30.1770
-11,130.3000
277.1190
Normalized EBITDA
-13,406.3930
-13,406.3930
-5,721.3300
-15,971.3030
-8,217.3350
Tax Rate for Calcs
0
0
0
0.0001
0
Tax Effect of Unusual Items
0
0
0
-1,135.4720
0
12/31/2021 - 12/12/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CMP.AX Compumedics Limited
0.2850
+3.64%
 
DYNT Dynatronics Corporation
0.0820
0.00%
 
ELMD Electromed, Inc.
22.27
+0.18%
 
BVS Bioventus Inc.
6.83
+0.37%
 
OFIX Orthofix Medical Inc.
12.42
+0.89%
 
VMD Viemed Healthcare, Inc.
6.33
-1.48%
 
CLPT ClearPoint Neuro, Inc.
14.59
+2.39%
 
NSYS Nortech Systems Incorporated
8.60
-0.58%
 
STIM Neuronetics, Inc.
4.5900
-1.29%